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Abstract
The Holt-Oram syndrome (HOS) is an autosomal dominant condition characterized by upper limb and cardiac mal-
formations. Mutations in the TBX5 gene cause HOS and have also been associated with isolated heart and arm de-
fects. Interactions between theTBX5,GATA4andNKX2.5 proteins havebeenreported inhumans. Wescreened the
TBX5, GATA4, and NKX2.5 genes for mutations, by direct sequencing, in 32 unrelated patients presenting classical
(8) or atypical HOS (1), isolated congenital heart defects (16) or isolated upper-limb malformations (7). Pathogenic
mutations in the TBX5 gene were found in four HOS patients, including two new mutations (c.374delG; c.678G > T)
in typical patients, and the hotspot mutation c.835C > T in two patients, one of them with an atypical HOS phenotype
involving lower-limb malformations. Two new mutations in the GATA4 gene were found in association with isolated
upper-limb malformations, but their clinical significance remains to be established. A previously described possibly
pathogenic mutation in the NKX2.5 gene (c.73C > 7) was detected in a patient with isolated heart malformations and
also in his clinically normal father.
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The Holt-Oram syndrome (HOS) (MIM #142900) is
an autosomal dominant condition that has an estimated fre-
quency of 1:100,000 live births (Basson et al., 1997) and
comprises malformation of the upper limbs (involving
mainly the pre-axial ray) and congenital heart defects
(CHD). Atypical phenotypes have also been described
(Brassington et al., 2003; Lehner et al., 2003; McDermott
et al., 2005; Garavelli et al., 2008) and may present as iso-
lated skeletal anomalies or cardiac defects (Lehner et al.,
2003) or may include renal, craniofacial, axillary, tracheal
and vertebral anomalies, deafness, abdominal situs
inversus(Brassingtonetal.,2003;McDermottetal.,2005),
andlower-limbmalformations(Garavellietal.,2008).Due
to the high variability of the phenotype, evaluation of the
apparently asymptomatic relatives is highly recommended
andshouldincludeanamnesis,upper-limbradiographs,and
cardiac evaluation by electrocardiogram (ECG) and
echocardiogram (ECO).
HOS is caused by mutations in the TBX5 gene (Li et
al., 1997; Basson et al., 1999). The TBX5 gene (MIM
*601620) maps to cytoband 12q24.1, belongs to the T-box
familyoftranscriptionfactors(Bassonetal.,1997;Lietal.,
1997) and is mainly expressed in the embryonic heart and
upper-limb tissues (Bruneau et al., 2001). Although the
TBX5 gene is responsible for most cases of HOS, the ge-
netic heterogeneity of the syndrome can lead to false diag-
nosis, causing the mutation rate in sporadic and atypical
cases to be underestimated (Mori and Bruneau, 2004).
The GATA4 gene (MIM *600576) is a member of the
GATA family of transcription factors, with expression
mainly restricted to the heart and gonad tissues (Charron
and Nemer, 1999). Protein GATA4 is one of the first tran-
scripts to be found in the developing heart, where it pre-
cedes the expression of earliest cardiac differentiation
markers (Charron and Nemer, 1999; Gilbert, 2006). Muta-
tions in the GATA4 gene have been found in patients with
congenital heart defects (Garg et al., 2003; Okubo et al.,
2004; Hirayama-Yamada et al., 2005; Sarkozy et al.,
2005), but no mutations have been related to upper-limb
malformations so far.
TheNKX2.5(MIM*600584)proteinplaysanimpor-
tant hole in the genesis of the heart. Mutations in the
NKX2.5 gene may lead to several types of cardiac malfor-
mations (Elliott et al., 2003). Previous studies have shown
that the GATA4 protein interacts with both the NKX2.5
(Durocher et al., 1997) and the TBX5 (Garg et al., 2003)
protein, and that these interactions can lead to upregulation
of cardiogenesis in cells under differentiation.
Because of the wide phenotypic variability found in
the HOS patients, we screened for mutations in the TBX5,
GATA4 and NKX2.5 genes in patients presenting with clas-
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Short CommunicationsicalHOS,classicalHOSwithfeetanomalies,patientswith
isolated upper-limb malformations, and patients with iso-
lated heart defects. We selected 32 unrelated patients and
classified them into four categories: typical HOS (n = 8),
atypical HOS (n = 1), isolated hand anomalies (n = 7), and
isolated heart defects (n = 16). Differential diagnosis for
known conditions such as VACTERL sequence and
Waardenburg syndrome was previously performed for ex-
clusion from the sample. Informed consent in accordance
with the guidelines established by the local institutional
ethics boards was obtained.
Genomic DNA was isolated from all patients, their
parents, and 50 healthy individuals, according to standard
methods (Miller et al., 1988). Primers used to analyze the
TBX5, GATA4, and NKX2.5 genes and the conditions for
the polymerase chain reactions (PCR) were the same as
previously described by other authors (Basson et al., 1997;
Garg et al., 2003; Basson et al., 1999, respectively). PCR
productsweresubmittedtodirectsequencing,usinganABI
Prism 3100 automatic sequencer according to manufac-
turer’s protocol. The obtained sequences were compared
with the wild-type TBX5 (RefSeq NM_000192.3), GATA4
(RefSeq NM_002052.3), or NKX2.5 (RefSeq
NM_004387.2) genomic sequences. The patients’ clinical
findings and detected mutations are listed in Table 1.
FouroutofeightpatientswithtypicalHOShadmuta-
tions in the TBX5 gene. Patient HH17, a woman with ASD
and triphalangeal thumbs (Figure 1A), had a previously de-
scribed pathogenic mutation (c.835C > T/ p.R279X) that
does not affect the TBX5-binding domain, but causes the
lossofitsC-terminalportion(Lietal.,1997),andisconsid-
eredahotspotmutation(Heinritzetal.,2005b).Thepatient
also carried a TBX5 c.309C > T mutation, in heterozygosis.
Thisisapolymorphicsilentmutationaccordingtothe“The
Human TBX5 Gene Mutation Database” (Heinritz et al.,
2005a). The patient’s son presented the same genotype, but
a milder phenotype: shortened arms and no CHD.
Patient HH20 had a de novo novel mutation
(c.374delG) in the TBX5 gene that resulted in a premature
stop codon. This mutation eliminated the binding domain
of the TBX5 protein, giving rise to a truncated protein with
only148aminoacids.Thispatienthadaveryseverepheno-
type,withbilateralupper-limbmalformations(bilateralhu-
merus hypoplasia, bilateral absence of the radius, three
metacarpal bones, and two phalangeal fingers on the right
side; and three metacarpal bones, and three phalangeal fin-
gers(twoofthemsyndactylic)ontheleftside,besidesase-
vere heart malformation characterized by ASD, a
ventricular septal defect and pulmonary hypertension (Fig-
ure 1B). Another previously described mutation, which re-
sulted in a premature stop codon at the same position, was
associated with the occurrence of a severe upper-limb mal-
formation, but no heart defects were mentioned for that pa-
tient (Yang et al., 2000).
A novel mutation, c.678G > T/ p.K226N, located
within the T-box domain of the TBX5 gene, was found in
patient HH24 and her father. Both of them presented with
severe congenital heart disease (OS-ASD, atrioventricular
septal defect, pulmonary stenosis, hypertension, and mitral
insufficiency), besides upper-limb and other malforma-
tions (triphalangeal thumbs, 11 pairs of ribs, and shortened
scapular bone; Figure 1C). This mutation was predicted to
impairthefunctionoftheTBX5protein(PSICscorediffer-
ence 1.966; PolyPhen), leading to hydrophobicity and
charge changes at buried site. It was not found in the 100
control chromosomes tested.
Patient HH25 had a c.804C > G mutation in the TBX5
gene, a silent mutation that is not expected to be the cause
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Table 1 - Clinical findings in patients with mutations
Patient Gender Phenotype Mutation
Typical HOS Atypical HOS Only hand defects Only heart defects Gene Exon Genotype
HH17 F Fam - - - TBX5 4 c.309C > T (SNP)
8 c.835C > T (p.R279X)
HH20 F Sp - - - TBX5 5 c.374delG (p.G125fsX149)
HH24 F Fam - - - TBX5 7 c.678G > T (p.K226N)
HH25 F Sp - - - TBX5 8 c.804C > G (SNP)
HH8 M - Sp* - - TBX5 8 c.835C > T (p.R279X)
HH2 F - - Sp - TBX5 4 c.309C > T (SNP)**
GATA4 4 c.[997+23A > T; 997+56C > A]
HH4 M - - Sp - GATA4 1 c.392C > G (p.A131G)
CHD1 M - - - Sp NKX2.5 1 c.73C > T (p.R25C)
GATA4 1 c543C > T (SNP)
CHD5 F - - - Fam TBX5 4 c.309C > T (SNP)
HOS: Holt-Oram syndrome. HH: heart-hand syndrome. CHD: congenital heart defect. Sp: sporadic cases. Fam: familial cases.
Bold: novel mutations and polymorphisms. *Feet anomaly. **Mutation found in homozygosis.of the typical HOS clinical features (ASD, VSD, mitral
valveinsufficiency,dilatationoftheleftatriumandthepul-
monaryartery,preaxialpolydactylyoftherightthumbwith
duplication of the distal phalanx (presence of nails was ob-
served on both the duplicated phalanges), distal implanta-
tion of the left thumb, mild hemithorax hypoplasia,
upper-limb supination limited to the right side, and a
sacralized transition vertebra; Figure 1D). The mutation
was not found in the 100 control chromosomes tested.
The atypical HOS patient HH8 had a de novo c.835C
>Tmutation,thesameasfoundinPatientHH17.Theclini-
cal findings were ostium secundum atrial septal defect
(OS-ASD) and upper-limb malformation
(brachymesophalangism of the fifth finger and high im-
plantation of the left thumb; Figure 1E), all of which are
commonfindingsinHOS(Lietal.,1997).Thispatientalso
presented lower-limb malformation (agenesis of the distal
phalanxofthefifthtoe),whichisanunusualfindingamong
HOS patients. A recent study (Garavelli et al., 2008) de-
scribes a family with three affected individuals, one of
which presents a foot anomaly. The authors included this
patient in the group of atypical Holt-Oram syndrome phe-
notypes. Faria et al. (2008) reported a TBX5 missense mu-
tation (V263M) in a Brazilian family with atrial septal
defect and postaxial hexadactyly of both feet.
In four of our typical HOS patients, no mutations
were detected. In addition to the possibility of the involve-
ment of other genes, large deletions in the investigated
genes might have gone undetected by direct sequencing
(Borozdin et al., 2006).
Two out of the 16 patients with isolated heart anoma-
lies had mutations in TBX5, GATA4, and NKX2.5. Patient
CHD5 carried the c.309C > T polymorphism in the TBX5
gene. Her parents did not have this polymorphism. She had
an isolated heart defect of the OS-ASD type, and her three
brothers presented valve defects, but they were not avail-
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Figure 1 - Upper-limb malformations found in patients. (A) HH17: triphalangeal thumbs. (B) HH20: at right, bilateral humerus hypoplasia and absence
of radius, three metacarpal bones, and two phalangeal fingers; at left, three metacarpal bones, and three phalangeal fingers, two of them syndactylic. (C)
HH24:triphalangealthumbs.(D)HH25:preaxialpolydactiliaoftherightthumbwithduplicationofthedistalphalanx(presenceofnailswasobservedon
boththeduplicatedphalanges),distalimplantationoftheleftthumb.(E)HH8:brachymesophalangismofthefifthfingerandhighimplantationoftheleft
thumb. (F) HH2: At left, radioulnar synostosis, and hypoplasia of the distal and middle phalanges of the first and fifth digits; at right, synostosis of ulna
andhumerus,hypoplasticradius,twodigitalraysofhand.(G)HH4:Atright,hypoplasticthumb(lowarticulated)andshortphalanges;atleft,radialdevi-
ation, and absence of the thumb.able for mutation analysis. Patient CHD1 presented a pre-
sumptively pathogenic mutation in the NKX2.5 gene
(c.73C > T/p.R25C), together with the c.543C > T poly-
morphism in the GATA4 gene. This patient had OS-ASD,
but his father who carried the same mutations showed no
heart malformation. The NKX2.5 p.R25C mutation was
previously described in patients with a wide spectrum of
congenital heart diseases, from conduction defects to
TetralogyofFallot(Bensonetal.,1999;McElhinneyetal.,
2003). However, the frequency of this mutation in black
control subjects was 4.7% (Goldmuntz et al., 2001), which
issuggestiveoflowpenetranceornoinvolvementinCHD.
Two out of the seven patients with isolated up-
per-limb anomalies had mutations in TBX5 and/or GATA4.
Patient HH2 had radioulnar synostosis of the left arm and
hypoplasia of the distal and middle phalanges of the first
and fifth digits (Figure 1F). At right, she had synostosis of
ulna and humerus, a hypoplastic radius, and only two digi-
tal rays of the right hand (the first-finger phalanges were
hypoplastic, and only two metacarpal bones were ob-
served), as shown in Figure F. No congenital heart disease
was diagnosed in the patient or in her family (ECO and
ECGwerenormal).MutationalanalysisoftheGATA4gene
showed two novel de novo intron mutations, c.[997+23A >
T; 997+56C > A], in the same allele. These mutations were
locatedfarfromthesplicingsites,andthepotentialinstabil-
ity of the mRNA remains to be accessed. They were not
found in the 100 control chromosomes tested. The patient
also presented the TBX5 c.309C > T polymorphism in
homozygosis.
Patient HH4 had a hypoplastic thumb with low im-
plantation and shortened phalanges of the right hand. The
left hand showed radial deviation and absence of the thumb
(Figure 1G). No congenital heart disease was observed in
him or his parents (ECO and ECG were normal). The
GATA4 gene showed a novel nonsense mutation, c.392C >
G (p.A113G), located in the transcriptional activation do-
main1.Thisvariantwaspredictedtobebenign(PSICscore
difference 1.191), according to the PolyPhen program
(Ramensky et al., 2002). It was not found in the patient’s
parents or in the 100 control chromosomes.
So far, GATA4 mutations have not been described in
association with isolated upper-limb defects, but this is a
possibility that deserves further investigation.
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